The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Key Finding
Berberine significantly improved blood glucose and lipid profiles, comparable to metformin, supporting metabolic brain health.
Plain-English Summary
This meta-analysis examined 11 randomized controlled trials evaluating berberine's effects on blood glucose and lipid profiles. Studies used doses of 500-1500mg daily over 8-24 weeks.
Berberine significantly reduced fasting blood glucose, HbA1c, triglycerides, and LDL cholesterol. Effects on glucose control were comparable to metformin in head-to-head comparisons. These metabolic improvements have important implications for brain health.
Metabolic dysfunction is increasingly linked to cognitive decline and neurodegeneration. By improving insulin sensitivity and reducing inflammation, berberine may protect brain function indirectly. Berberine also activates AMPK, a cellular energy sensor that supports autophagy and mitochondrial health. Recent research suggests berberine may cross the blood-brain barrier and have direct neuroprotective effects.